WolverHeme

A hematology podcast by @berninini, @ajperissinotti, and friends! We nerd out and have a few drinks along the way!

Disclaimer: views are our own!

[WolverHeme @WolverHeme]

@Berninini @ajperissinotti

[WolverHeme @WolverHeme]

The hottest take in myeloma right now:

☠️ “Cilta-cell is dead.”

With bispecifics delivering impressive results has CAR-T lost its crown?

We brought in @ManniMD1 for a discussion that every myeloma clinician should hear.

🎧 Listen here: https://t.co/emTP22tNgw

[Andrius Žučenka @zucenka]

As a die hard transplanter, I’ve always found BMT to be a rather conservative-empyric field of hematology and it was driving me crazy sometimes. Such a great podcast highlighting this!

But with so many recent novelties in BMT, I think there’s less room for cult-like practices😅

[Papa Heme @Papa_Heme]

Been a while since I did a podcast. Fun times as always with WolverHeme

[WolverHeme @WolverHeme]

Check out our latest episode "Cult-Like Thinking in BMT" with @Papa_Heme @FeeneyTate @ajperissinotti @Berninini! Comment below 👇what "cult-like" practices you've seen in medicine! https://t.co/x1JXzfSnfA

[Bernie Marini @Berninini]

Young clinicians don’t need to make critical appraisal their primary academic focus, but it is a skill every clinician MUST learn as early as possible. No trial is perfect but understanding the implications of imperfections is 🔑.

And remember - critique trials, not people!

[WolverHeme @WolverHeme]

👀Special VIDEO episode is out, where we do some "Spring Cleaning" 🌞🧹of #ASH25 abstracts! Moderated by @Berninini @ajperissinotti @csoncol, with special guests @Eddie_Cliff @RobertaDemiche3 @ManniMD1 #Commonsenseoncology https://t.co/tVZ6tZCqzg

[WolverHeme @WolverHeme]

Want to learn about HLH? Check out our latest episode - "HLH: From Chaos to Clarity... and Back to Chaos" with @JKanerMD @maddyochs @ajperissinotti @Berninini and Cathy Johnson! https://t.co/rT5tSvGIAj

[WolverHeme @WolverHeme]

@ajperissinotti @Berninini

[WolverHeme @WolverHeme]

👉 Must-listen. Full stop.
🎙️ join us with Jonathan Gluck — award-winning journalist (New York Magazine, Vogue, Medium) and author of An Exercise in Uncertainty — to talk about life with multiple myeloma and the uncertainties of modern oncology practice
🎧 https://t.co/j4IG4UAgce

[WolverHeme @WolverHeme]

Listen to our latest episode with special guest @JKanerMD, "ASH Leukemia Review: the more we learn, the less we know!" @Berninini @ajperissinotti #twitteRx #leusm #ASH25 https://t.co/m4eST9yXwa

[WolverHeme @WolverHeme]

@RBeechPharmD Well played haha

[WolverHeme @WolverHeme]

🚨It has come to our attention our podcast is censored in some countries!

Here’s a link to a free MP3 download!

https://t.co/yWOW7TJaok

Cheers 🍻

(It’s not Canada, we are proudly 50%+ 🇨🇦)

[WolverHeme @WolverHeme]

@Papa_Heme https://t.co/aEANZYXBiU

[WolverHeme @WolverHeme]

RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy. Listen to our take on the #PARADIGM #Plenary from #ASH25 @ajperissinotti @Berninini https://t.co/oVQCvnyRYm

[WolverHeme @WolverHeme]

RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy. Listen to our take on the #PARADIGM #Plenary from #ASH25 @ajperissinotti @Berninini https://t.co/oVQCvnyRYm

[Anurag Singh @aksinghmd]

Only discussion to make sense of what is really important in Myeloma and what really matters to the patients.

[Papa Heme @Papa_Heme]

If you want to hear actual critical analysis of myeloma trials instead of cheerleading listen to this. The best podcast in heme.

[WolverHeme @WolverHeme]

This Thanksgiving, we're thankful for the Myeloma Man Manni Mohyuddin, who came on the podcast to discuss the key #ASH25 abstracts in multiple myeloma, including the results of the #MajesTEC-3 trial! Cheers! 🍻🙏🦃 @Berninini @ajperissinotti @ManniMD1 https://t.co/23HwMRmQ94

[WolverHeme @WolverHeme]

Come have a 🍺 or ☕️ and join @ajperissinotti, @Berninini, and special guest Dr. Luke Fletcher @LFletcherMD15 in our discussion of innovations and best practices in community hematology! https://t.co/vu5U3k3ZYd

[Andrius Žučenka @zucenka]

Great points made on the most common complication in intensively treated hem-onc pts! I wasn’t aware that up to the 1960s-1970s empirical antibiotics were not given for FN, and this may also partially explain why we have the landmark paper on success of 7+3 induction in 1973 🧫💊